Panchsheel Organics Share Price & Earnings Call Analysis

₹100.98-1.84% today

Market cap: ₹133 Cr
P/E: 12.92
ROE: 7.89%
PEG: -1.55
Price to sales: 1.24
Debt to equity: 0.04
52W high / low: ₹147 / ₹90.2
Sales growth (5Y): 16.63%
EBITDA margin: 12.09%
Net profit margin: 10.14%
Promoter holding: 56.12%
Sales (last year): ₹108 Cr

All 12 ratios ↓

Potential multibaggers · Q2 FY27

Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance

See all potential multibaggers Where does Panchsheel Organics rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

1. Pick 3–15 stocks
2. Choose large, mid or small cap and your sectors
3. Get a portfolio built from the rankings

Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Pharmaceuticals & Biotechnology companies ranked on guidance

#	Company	Revenue guided	Margin guided	Market cap	P/E
1		40%+	Up 2%+	₹480 Cr	19.1
2		40%+	Up 0–2%	₹212 Cr	16.1
3		40%+	Flat	₹17,925 Cr	—
4		40%+	Flat	₹5,223 Cr	39.1
5		40%+	Flat	₹4,268 Cr	—
6		40%+	Flat	₹40 Cr	—

Sign up free to see every company in the sector ranking and track Panchsheel Organics.

Pro shows every company guiding 40%+ revenue growth →Full Pharmaceuticals & Biotechnology ranking

Financials of Panchsheel Organics

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Panchsheel Organics

Quarterly Results

Quarter-by-quarter operating performance

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales +	27.96	29.53	24.63	23.71	25.61	31.27	26.05	27.18	26.24	28.37	23.56	25.32	26.73
Expenses +	22.24	25.58	19.75	19.28	20.70	26.54	21.62	22.05	21.70	23.60	19.81	21.82	22.95
Operating Profit	5.72	3.95	4.88	4.43	4.91	4.73	4.43	5.13	4.54	4.77	3.75	3.50	3.78
OPM %	20.46%	13.38%	19.81%	18.68%	19.17%	15.13%	17.01%	18.87%	17.30%	16.81%	15.92%	13.82%	14.14%
Other Income +	0.01	1.17	0.10	1.01	1.22	0.13	0.74	0.70	0.96	0.00	0.66	0.64	1.06
Interest	0.18	0.23	0.07	0.11	0.05	0.05	0.06	0.14	0.08	0.09	0.06	0.08	0.09
Depreciation	0.31	0.64	0.38	0.41	0.39	0.56	0.54	0.56	0.58	0.51	0.56	0.58	0.60
Profit before tax	5.24	4.25	4.53	4.92	5.69	4.25	4.57	5.13	4.84	4.17	3.79	3.48	4.15
Tax %	25.19%	30.12%	25.17%	25.20%	25.13%	34.59%	24.95%	26.12%	24.17%	23.98%	25.07%	25.00%	11.33%
Net Profit +	3.92	2.99	3.39	3.69	4.26	2.78	3.43	3.79	3.67	3.17	2.85	2.61	3.68
EPS in Rs	3.33	2.54	2.88	3.13	3.62	2.11	2.60	2.88	2.79	2.41	2.16	1.98	2.79

Financials of Panchsheel Organics

Profit & Loss

Annual income statement trend

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	39	36	40	40	42	48	50	49	69	103	105	107	104
Expenses +	35	31	34	33	35	41	42	41	56	83	86	90	88
Operating Profit	4	5	6	7	7	7	9	9	13	20	19	18	16
OPM %	11%	13%	14%	17%	16%	14%	17%	18%	19%	19%	18%	16%	15%
Other Income +	0	0	0	0	0	0	0	0	0	1	2	3	2
Interest	1	1	1	0	1	0	0	0	0	1	0	0	0
Depreciation	1	1	1	1	1	1	1	1	1	2	2	2	2
Profit before tax	3	3	4	5	5	6	7	7	11	19	19	18	16
Tax %	35%	32%	27%	36%	29%	29%	28%	31%	27%	26%	27%	24%
Net Profit +	2	2	3	3	4	4	5	5	8	14	14	14	12
EPS in Rs	1.76	1.90	3.04	3.21	3.67	4.04	5.29	5.01	8.33	11.94	10.71	10.47	9.34
Dividend Payout %	14%	13%	17%	16%	14%	12%	0%	20%	18%	7%	7%	8%

Financials of Panchsheel Organics

Balance Sheet

Capital structure and asset base

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	5	5	5	5	5	5	5	5	10	12	13	13	13
Reserves	12	13	16	19	22	25	30	35	37	84	112	121	125
Borrowings +	5	7	5	7	6	5	4	4	4	6	6	5	4
Other Liabilities +	12	8	11	9	12	9	12	14	22	21	28	24	29
Total Liabilities	35	33	37	39	44	44	52	58	74	123	159	163	171
Fixed Assets +	8	7	7	8	7	7	6	7	7	8	14	18	19
CWIP	0	0	2	2	2	2	2	2	2	4	6	15	17
Investments	0	0	0	0	0	0	0	0	0	0	3	0	0
Other Assets +	28	26	28	30	36	36	44	49	65	111	137	131	135
Total Assets	35	33	37	39	44	44	52	58	74	123	159	163	171

Financials of Panchsheel Organics

Cash Flows

Operating, investing and financing cash movement

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	3	1	3	1	3	2	5	5	-2	0	10	4
Cash from Investing Activity +	-1	-1	-2	-2	-1	-1	-2	-1	-0	-34	-7	-16
Cash from Financing Activity +	-2	0	-1	1	-2	-2	-1	-2	-1	36	16	-5
Net Cash Flow	0	0	-1	0	-0	0	1	3	-2	1	18	-18
Free Cash Flow	2	-0	-0	-1	2	1	4	3	-3	-4	-0	-12
CFO/OP	88%	46%	69%	45%	79%	63%	73%	85%	5%	28%	82%	48%

Financials of Panchsheel Organics

Ratios

Working capital efficiency and return ratios

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	130	142	134	138	170	137	164	140	172	137	137	119
Inventory Days	124	154	155	185	185	164	186	246	237	181	211	246
Days Payable	108	80	109	83	124	73	111	152	158	89	114	88
Cash Conversion Cycle	146	216	181	240	231	229	239	235	251	230	234	276
Working Capital Days	104	136	138	137	150	155	170	167	192	173	178	204
ROCE %	15%	14%	19%	20%	18%	18%	20%	19%	25%	26%	17%	14%

Others in Pharmaceuticals & Biotechnology this season

Anthem Bioscienc (Q2 FY27)
Q2FY27 Consolidated Revenue from Operations: ₹5,940 Mn, up 7.9% YoY from ₹5,505 Mn in Q2FY26 (Page 4). Key investor presentation takeaways from Anthem Bioscienc
Neuland Laboratories (Q2 FY27)
Q2FY27 Total Income (revenue) was ₹457.2 crore, down 11.4% year-on-year (YoY) from Q2FY26. Key investor presentation takeaways from Neuland Laboratories Ltd's Q
Hikal (Q2 FY27)
Consolidated Revenue Q2FY27:** ₹434 crores, up 36% YoY from ₹319 crores in Q2FY26 (Page 9) . Key investor presentation takeaways from Hikal Ltd's Q2 FY27 invest
Kopran (Q2 FY27)
9,335 lakhs (~79% increase) . Key investor presentation takeaways from Kopran Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Sun Pharmaceutical Industries vs Divis Laboratories vs Torrent Pharmaceuticals